Trial Profile
A retrospective study of tofacitnib for the treatment of Alopecia Areata and Variants
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Jun 2017
Price :
$35
*
At a glance
- Drugs Tofacitinib (Primary)
- Indications Alopecia areata
- Focus Therapeutic Use
- 19 Nov 2016 New trial record
- 02 Nov 2016 Results published in the Journal of the American Academy of Dermatology